Role of ABCG1 in Zika virus induced chorioretinal atrophy
ABCG1 在寨卡病毒诱导的脉络膜视网膜萎缩中的作用
基本信息
- 批准号:9436896
- 负责人:
- 金额:$ 19.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-02-01 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAddressAdultAnimalsAntiviral AgentsAntiviral ResponseAtrophicAttenuatedBindingBiological ProcessBlood-Borne PathogensBlood-Retinal BarrierBrazilCASP3 geneCandidate Disease GeneCell DeathCellsCeramidesCholesterolCholesterol HomeostasisChorioretinitisClinicalClinical ResearchCongenital DisordersConsequentialismDataDatabasesDengueDiseaseDisease OutbreaksEarEventEyeFamilyFatty AcidsFlavivirusFunctional disorderGene SilencingGenesGoalsHealthHepatitis CHistologyHumanImmune responseIn Situ Nick-End LabelingIn VitroInfantInfectionInflammatory ResponseInnate Immune ResponseIntegration Host FactorsInterferonsInternationalJapanese EncephalitisKnock-outLaboratoriesLesionLimb structureLinkMembrane Transport ProteinsMeta-AnalysisMetabolismMicrocephalyMolecularMusNeurologic SymptomsNeuronsOcular PathologyOntologyOrganOutcomePathogenesisPathologicPathologyPharmacologyPregnancyPreventionProductionPropertyReportingRetinaRetinalRetinal DiseasesRoleSRE-2 binding proteinSecondary toStructure of retinal pigment epitheliumSupplementationSystems BiologyTestingTherapeuticTissuesUveitisValidationVascular EndotheliumViral load measurementVirusVirus ReplicationVisualWest Nile virusWorkZIKV infectionZika Virusbasecell typechemokinecholesterol biosynthesischolesterol transporterscytokinedesigndisorder of macula of retinadrug developmentfundus imagingglobal healthin vivoinsightinterestlipid biosynthesislipid metabolismlipid transportmacrophagemaculamembermicrobialmouse modelnervous system disorderpathogenpreventpublic health emergencyreceptorrecombinase-mediated cassette exchangeresponseretinal damagetranscriptometranscriptome sequencingvirus pathogenesis
项目摘要
Project Summary
The most recent outbreak of Zika Virus (ZIKV) in Brazil has presented with unexpectedly severe
neurological manifestations, which were not observed in prior outbreaks of ZIKV or other related
flaviviruses. This prompted the WHO to declare a public health emergency of international
In addition to neurologic disorders, ZIKV infection is now being increasingly
associated with ocular complications such as uveitis, acute maculopathy, pigmentory
retinopathy, and chorioretinal atrophy. These clinical findings make it clear that macular and
chorioretinal disease can significantly impact visual outcomes in ZIKV-infected infants and
adults. However, it is not yet clear whether congenital ocular complications are directly caused
by ZIKV or are secondary to microcephaly. As the retina is the primary target of ZIKV in the
eye, we have developed a mouse model of ZIKV-induced chorioretinal atrophy. We found that
cells lining the blood-retinal barrier (BRB), the retinal pigment epithelium (RPE), are highly
permissive to ZIKV. Collectively, these findings led us to postulate that ZIKV gains access to
the eye by via BRB. Despite the close relationship between ZIKV and other members of the
flaviviridae family, such as DENV, WNV, and JEV, it remains unclear why only ZIKV causes
congenital disorders and associated complications. To address this question , we compared
the transcriptome of ZIKV-infected RPE cells with the transcriptome signatures of the other
related viruses. This led to the identification of ABCG1, a cholesterol membrane transporter,
as a candidate gene that is specifically involved in the pathogenesis of ZIKV. In support, our
preliminary data show that pharmacological inhibition of ABCG1 activity attenuated ZIKV
replication in RPE cells. Thus, the overall objective of this study
concern.
is to determine molecular
mechanisms by which ABCG1 promotes viral replication in RPE and determine the
consequences of ABCG1 ablation in the pathobiology of ZIKV-induced chorioretinal atrophy. To
achieve this goal, we will pursue two specific aims: Aim-1 is to determine how ZIKV-induced
ABCG1 expression modulates cholesterol synthesis/efflux to promote ZIKV replication in RPE
cells. Aim-2 is designed to investigate the role of ABCG1 in the pathobiology of ZIKV-induced
chorioretinal atrophy in ABCG1-BEST1Cre mice harboring an RPE-specific conditional knockout.
Upon completion, these aims will elucidate the role of ABCG1 in ocular ZIKV infection,
particularly in the pathogenesis of chorioretinal atrophy. Given the rapid spread of ZIKV and its
impact on ocular health, this work is of paramount importance for the development of drugs to
treat ZIKV infection and prevent its complications.
项目摘要
寨卡病毒(ZIKV)在巴西的最新爆发已经呈现出意想不到的严重
神经系统表现,这在ZIKV或其他相关疾病的先前爆发中没有观察到。
黄病毒这促使世界卫生组织宣布国际公共卫生紧急状态
除了神经系统疾病,ZIKV感染现在越来越多地被
与眼部并发症如葡萄膜炎、急性黄斑病变、色素沉着
视网膜病和脉络膜视网膜萎缩。这些临床发现清楚地表明,黄斑和
脉络膜视网膜疾病可显著影响ZIKV感染婴儿的视力结果,
成年人了但目前尚不清楚先天性眼部并发症是否直接引起
或继发于小头畸形。由于视网膜是ZIKV在视网膜病变中的主要靶点,
眼,我们已经开发了ZIKV诱导的脉络膜视网膜萎缩的小鼠模型。我们发现
内衬血视网膜屏障(BRB)的细胞,即视网膜色素上皮(RPE),高度
允许ZIKV。总的来说,这些发现使我们假设ZIKV获得了
通过BRB的眼睛。尽管ZIKV和其他成员之间的密切关系,
尽管ZIKV是黄病毒科家族的成员,例如DENV、WNV和JEV,但仍然不清楚为什么只有ZIKV引起
先天性疾病和相关并发症。为了解决这个问题,我们比较了
ZIKV感染的RPE细胞的转录组与另一个细胞的转录组特征
相关病毒这导致了ABCG 1的鉴定,ABCG 1是一种胆固醇膜转运蛋白,
作为特异性参与ZIKV发病机制的候选基因。为了支持,我们的
初步数据显示ABCG 1活性的药理学抑制减弱了ZIKV
在RPE细胞中复制。因此,本研究的总体目标
关心
是确定分子
ABCG 1促进RPE中病毒复制的机制,并决定了
ABCG 1消融在ZIKV诱导的脉络膜视网膜萎缩的病理生物学中的后果。到
为了实现这一目标,我们将追求两个具体目标:目标-1是确定ZIKV如何诱导
ABCG 1表达调节胆固醇合成/流出以促进RPE中的ZIKV复制
细胞目的-2旨在研究ABCG 1在ZIKV诱导的肿瘤病理学中的作用。
携带RPE特异性条件性敲除的ABCG 1-BEST 1Cre小鼠中的脉络膜视网膜萎缩。
完成后,这些目标将阐明ABCG 1在眼部ZIKV感染中的作用,
特别是在脉络膜视网膜萎缩的发病机制中。鉴于ZIKV的快速传播及其
影响眼部健康,这项工作对于药物的开发至关重要,
治疗ZIKV感染并预防其并发症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ashok Kumar其他文献
Ashok Kumar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ashok Kumar', 18)}}的其他基金
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10621913 - 财政年份:2022
- 资助金额:
$ 19.25万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10373627 - 财政年份:2022
- 资助金额:
$ 19.25万 - 项目类别:
Age-associated impaired executive function: Rescue by NMDA receptor upregulation
与年龄相关的执行功能受损:通过 NMDA 受体上调来挽救
- 批准号:
10033493 - 财政年份:2020
- 资助金额:
$ 19.25万 - 项目类别:
Role of AMP-activated protein kinase in bacterial endophthalmitis - Diversity Supplement
AMP 激活蛋白激酶在细菌性眼内炎中的作用 - Diversity Supplement
- 批准号:
10206590 - 财政年份:2017
- 资助金额:
$ 19.25万 - 项目类别:
Role of AMP-activated protein kinase in bacterial endophthalmitis
AMP 激活蛋白激酶在细菌性眼内炎中的作用
- 批准号:
9899998 - 财政年份:2017
- 资助金额:
$ 19.25万 - 项目类别:
Targeting NAD metabolism to ameliorate bacterial endophthalmitis
靶向 NAD 代谢改善细菌性眼内炎
- 批准号:
10445516 - 财政年份:2017
- 资助金额:
$ 19.25万 - 项目类别:
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis
细菌性眼内炎的炎症消退机制
- 批准号:
10231125 - 财政年份:2017
- 资助金额:
$ 19.25万 - 项目类别:
Targeting NAD metabolism to ameliorate bacterial endophthalmitis
靶向 NAD 代谢改善细菌性眼内炎
- 批准号:
10621770 - 财政年份:2017
- 资助金额:
$ 19.25万 - 项目类别:
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis
细菌性眼内炎的炎症消退机制
- 批准号:
10002232 - 财政年份:2017
- 资助金额:
$ 19.25万 - 项目类别:
Toll-like receptors and bacterial endophthalmitis
Toll样受体与细菌性眼内炎
- 批准号:
8387011 - 财政年份:2010
- 资助金额:
$ 19.25万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 19.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 19.25万 - 项目类别:
Standard Grant